Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05184933 · ClinicalTrials.gov registry record · NA
Sleep and Circadian Mechanisms in Hypertension
A NA study of Hypertension and Cardiovascular Diseases, sponsored by Oregon Health and Science University.
- Recruiting
- Registry status
- NA
- Development phase
- 32
- Enrollment target
- 1
- Study location
NCT05184933: Recruiting NA study of Hypertension and Cardiovascular Diseases, sponsored by Oregon Health and Science University.
NCT05184933 is a NA study of Hypertension and Cardiovascular Diseases that is actively recruiting participants, run by Oregon Health and Science University. The registered enrollment target is 32 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05184933, a NA study of Hypertension and Cardiovascular Diseases, is actively recruiting participants, sponsored by Oregon Health and Science University.
- RECRUITING
- Registry status
- NA
- Development phase
- 32 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is a mechanistic clinical trial designed to investigate the effects of the circadian system and sleep on non-dipping blood pressure (BP) in people with hypertension (HTN).
Primary Outcome
Sleep duration will be scored from the ActiGraph and correlated with the sleep and activity diary. Sleep duration measures the amount of time asleep (in minutes).
Conditions Studied
Interventions
- BEHAVIORAL Regularized Sleep Schedule
- OTHER At-home Polysomnography
- OTHER Circadian Protocol
- OTHER Rested Wakefulness Trial
- OTHER Overnight Sleep Trial
Study Locations (1)
Oregon
- Oregon Health and Science University - Portland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2022-08-04 |
| Est. Completion | 2029-03-30 |
| Phase | NA |
What NCT05184933 shows while recruiting
NCT05184933 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 32 participants, a relatively small participant target, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (99% lower).
The record links to 5 conditions, with Hypertension appearing as the primary indexed condition, and to 5 interventions - of which Regularized Sleep Schedule is the first listed.
NCT05184933 reports a single indexed study location in Oregon.
Frequently Asked Questions
What is clinical trial NCT05184933 about?
NCT05184933 is a clinical study titled "Sleep and Circadian Mechanisms in Hypertension". This study is a mechanistic clinical trial designed to investigate the effects of the circadian system and sleep on non-dipping blood pressure (BP) in people with hypertension (HTN).
What is the current status of trial NCT05184933?
This trial is currently recruiting. It is a NA study. The enrollment target is 32 participants. The study started on 2022-08-04. Estimated completion is 2029-03-30.
What conditions does trial NCT05184933 study?
This clinical trial studies the following conditions: Hypertension, Cardiovascular Diseases, Sleep, Cardiovascular Risk Factors, Circadian Rhythms.
What interventions are being tested in trial NCT05184933?
The interventions under investigation include: Regularized Sleep Schedule (BEHAVIORAL), At-home Polysomnography (OTHER), Circadian Protocol (OTHER), Rested Wakefulness Trial (OTHER), Overnight Sleep Trial (OTHER).
Who is sponsoring clinical trial NCT05184933?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05184933 being conducted?
This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypertension
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05184933's enrollment target sits among peer trials
32 406th of 470 higher than 65 of 470 other Hypertension trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hypertension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Ketone Ester And Salt (KEAS) in Older Adults
RECRUITING · NA
-
How a Mediterranean Diet With Potatoes Impacts Heart and Metabolic Health in Adults With Pre-Diabetes
RECRUITING · NA
-
Conical Forearm and Cylindrical Upper Arm Non-Invasive Blood Pressure (NIBP) Measurements in Pregnant Patients
RECRUITING · NA
-
Comparing Healthcare Visit Recording and Open Notes to Improve Chronic iLlness Care Experience in Older Adults
RECRUITING · NA
-
Early Time-Restricted Eating in Older Adults With Hypertension
RECRUITING · NA
-
Targeting Metabolic Syndrome From the Emergency Department Through Mixed-Methods: Pilot Trial
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02445781 · 32 participants · Early Phase 1
Differing Levels of Hypoglycemia
- NCT02792270 · 32 participants · NA
Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT
- NCT03068910 · 32 participants · Early Phase 1
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
- NCT03208868 · 32 participants · NA
Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI